Health Capital Helsinki
  • Home
  • Why Helsinki Metropolitan
  • About
  • News
  • Events
  • Opportunities
  • Careers
  • Contact
  • Search
  • Menu Menu
Helsinki Partners / Janne Hirvonen
Nov 10, 2022

HUS, University of Helsinki and Janssen to start a unique collaboration

HUS Helsinki University Hospital, University of Helsinki, Janssen Finland and Janssen EMEA have agreed on extensive international collaboration. Its aim is to promote the development of value-based healthcare and to carry out research and development especially related to precision medicines.

HUS Helsinki University Hospital, University of Helsinki, pharmaceutical company Janssen Finland and Janssen EMEA (Europe, Middle East, and Africa region) are starting international collaboration. The agreement enables multi-year projects in different areas of disease treatment. At the beginning of the cooperation, the focus will be on improving the conditions for clinical trials and the treatment of depression, and other jointly agreed topics.

“We are supporting the change towards value- and outcome-based health care, where the actual health benefits of treatment for patients and healthcare service providers is measured. In practice, this means, for example, building relevant outcome-based impact trackers, and shifting the focus from measuring performance to created value”, says Nina Ekholm-Wenberg, Country Director at Janssen Finland.

The themes of the collaboration projects are selected according to their societal significance.

“We focus especially on health challenges that involve significant societal losses, such as long-term sick leave and even premature retirement. The situation is challenging both at the individual and societal levels”, Ekholm-Wenberg adds.

Themes of the collaboration projects are selected according to their societal significance.

The collaborating parties will also work together to conduct clinical trials and to enhance the better use of real-life data (RWE studies), in decision-making. In addition to this, the goal is to develop a job rotation model, or talent exchange program between partners.

“It is great that HUS’s research and development cooperation is expanding with this agreement. In addition to the fact that patients benefit from research-based healthcare development, this kind of international cooperation is also significant in attracting research and development-oriented healthcare professionals to work at HUS, as well as giving aid in retaining the experts already working for us”, says Taneli Raivio, Research Director at HUS Helsinki University Hospital.

The sharing and development of expertise between the contracting parties is also important for the University of Helsinki.

“One important part of the collaboration is the development of healthcare competence and educational cooperation between the contracting parties. This gives us new perspectives while developing the future of healthcare,” says Anne Remes, Dean of the University of Helsinki and Professor of Neurology.

News in Finnish

More information:

HUS Helsinki University Hospital
Taneli Raivio, Research Director, Professor taneli.raivio@hus.fi

University of Helsinki
Anne Remes, Dean, Faculty of Medicine anne.remes@helsinki.fi

Janssen
Nina Ekholm-Wenberg, CEO
NEkholmW@its.jnj.com

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn

More news

Health Capital Helsinki

Close-up of unrecognizable woman using nasal sprayMarko Verch / Flickr

Researchers developed a potential key for future pandemics

Mar 31, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2023/03/Woman-nasal-spray_Flickr-1500x1000-1.jpg 1001 1500 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-03-31 12:47:332023-03-31 12:49:24Researchers developed a potential key for future pandemics
MVision AI software on a laptopMVision AI

Helsinki-based MVision AI raises EUR5.4M to speed up cancer treatment

Mar 27, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2023/03/MVision-image-w1200.jpg 675 1200 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-03-27 15:16:222023-03-29 14:41:55Helsinki-based MVision AI raises EUR5.4M to speed up cancer treatment
Two researchers in white coats walkingKeksi Agency via City of Helsinki

TILT Biotherapeutics, rising superstar of oncolytic immunotherapy

Mar 21, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2020/04/Keksi-Agency-via-City-of-Helsinki_communications.jpg 1653 2480 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-03-21 08:00:272023-03-29 15:04:22TILT Biotherapeutics, rising superstar of oncolytic immunotherapy
All news

Health Capital Helsinki

Helsinki Partners
Kasarmikatu 36
00130 HELSINKI
FINLAND

Privacy notice

Sign up to our newsletter

Subscribe

Follow us

  • twitter
  • linkedin
Health Capital Helsinki
Scroll to top

We use cookies to give you the best experience on our website.

Find out more and set your preferences settings.

Powered by  GDPR Cookie Compliance
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential website cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are necessary to deliver the website as intended, refusing them will have impact how our site functions. You can always block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will prompt you to accept or refuse cookies every time you revisit our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Third party cookies

This website uses Twitter's and LinkedIn's cookies to help us improve our content and reach.

Please enable essential website cookies first so that we can save your preferences!

Privacy notice

You can read about how we use your data on our Privacy notice page.

Privacy notice